Indian stocks: Visit www.stage2stocks.com →

COMPASS Pathways Plc

Stage 3 · Topping · week 1

As of Oct 22, 2026, COMPASS Pathways is in Stage 3, the topping phase, now in its first week (since Oct 21, 2026). It closed at $11.63, 23.4% below its 52-week high and above its 200-day average, which is rising.

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. More about the company

$11.63
-1.44% today
$1.6B · Small cap
Market Neutral — Building

Pro read

Pro

Our read

Topping: the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is CMPS early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 33w
S2 28w
S2 25w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 4w → S2 1w → S1 1w → S4 13w → S1 5w → S2 10w → S3 8w → S4 12w → S1 5w → S4 33w → S1 8w → S4 2w → S1 3w → S4 2w → S2 28w → S3 5w → S2 25w → S3 1w current
Total tracked: 165 weeks across 18 stage runs.

CMPS among Medical Care Facilities11th of 49 by relative strength

All 49 →
Stocks in Medical Care Facilities ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AGLStage 3 · wk 898+6.8%
2PACSStage 3 · wk 498+15.7%
3LFSTStage 2 · wk 2497+4.0%
4AMNStage 2 · wk 2596+38.1%
5NHCStage 2 · wk 5995+8.4%
6CONStage 2 · wk 2294+14.9%
7INNVStage 3 · wk 593+5.8%
8MDStage 2 · wk 2692+14.3%
…11CMPSStage 3 · wk 192−15.4%
vs 52W High
-23.4%
$4.94 lo$15.19 hi
23.4% below 52W high, weakening from peak
The stock is rolling over from its 52-week high. In Stage 3 distribution, new long positions carry high risk.
Stage Maturity
Week 1
1w13w26w
Week 1, early distribution
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
13.2%
200 DMA: $10.27 · rising
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
0.50x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution, with institutions exiting. Stage analysis reads that as a warning against new long positions.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-15.4%
3M
+3.3%
6M
+27.1%
YTD
+77.6%
1Y
+78.9%
Scan Membership
Breakout Watch
Latest: 2024-01-31
3 appearances in last 60 days. First seen: 2022-09-07.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S3
Wk 1 · Vol 0.50x
2026-10-21S32→3
Wk 1 · Vol 0.47x
2026-10-20S2
Wk 25 · Vol 1.25x
2026-10-19S2
Wk 25 · Vol 1.22x
2026-10-16S2
Wk 25 · Vol 1.88x
2026-10-15S2
Wk 24 · Vol 1.02x
2026-10-14S2
Wk 24 · Vol 0.92x
2026-10-13S2
Wk 24 · Vol 0.68x
2026-10-12S2
Wk 24 · Vol 0.71x
2026-10-09S2
Wk 24 · Vol 0.83x
2026-10-08S2
Wk 23 · Vol 1.03x
2026-10-07S2
Wk 23 · Vol 0.57x
Moving averages & range
50 DMA
$13.15
200 DMA
$10.27
52W High
$15.19
52W Low
$4.94
5D Low
$10.75
Resistance levels (recent highs)
20d High
$13.23
60d High
$15.19
120d High
$15.19
250d High
$15.19
Next resistance
+13.8%
to 20d High
ROE
-319.1%
Profit margin 0.0%
Dividend Yield
0.00%
P/B 18.7

COMPASS Pathways: quick answers

What stage is COMPASS Pathways in?

As of Oct 22, 2026, COMPASS Pathways (CMPS) is in Stage 3, the topping phase. It entered Stage 3 on Oct 21, 2026 and is in its first week there. What the four stages mean

Is COMPASS Pathways in an uptrend?

Its uptrend has stalled. COMPASS Pathways is in Stage 3, the topping phase that follows an advance. It trades 13.2% above its 200-day average, which is rising.

How far is COMPASS Pathways from its 52-week high?

COMPASS Pathways closed at $11.63 on Oct 22, 2026, 23.4% below its 52-week high of $15.19. Its 52-week low is $4.94.

How has COMPASS Pathways performed over the past year?

As of Oct 22, 2026, COMPASS Pathways is up 78.9% over the past year and up 77.6% so far in 2026.

Which sector and industry is COMPASS Pathways in?

COMPASS Pathways is in the Medical Care Facilities industry, part of the Health Care sector.

About this companyHealth Care· Medical Care Facilities

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.